Open access
Open access
Powered by Google Translator Translator

USPSTF Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease.

27 Apr, 2022 | 08:16h | UTC

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement – JAMA

Author Interview: USPSTF Recommendation: Aspirin Use for Cardiovascular Disease – JAMA

Modeling Study: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force – JAMA

Evidence Report: Aspirin Use to Prevent Cardiovascular Disease and Colorectal CancerUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Patient Page: Use of Aspirin to Prevent Cardiovascular Disease – JAMA

Editorials:

Should Patients Take Aspirin for Primary Cardiovascular Prevention? Updated Recommendations From the US Preventive Services Task Force

Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma – JAMA Internal Medicine

Aspirin for Primary Prevention—Time to Rethink Our Approach – JAMA Network Open

USPSTF Report on Aspirin for Primary Prevention – JAMA Cardiology

Commentaries:

USPSTF Report on Aspirin for Primary Prevention – American College of Cardiology

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention – TCTMD

Daily aspirin offers little to no benefit for most adults trying to prevent heart disease, new report says – STAT

U.S. Task Force Rejects Daily Aspirin for Heart Health in People Over 60 – HealthDay

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.